The company will also make available its new tablet-based version of SignosRT Bladder scanner for customers in Europe.

Signostics EMEA business development vice-president Steven Haken said the SignosRT Bladder products could help save money and get patients home sooner.

"Catheterization of patients with suspected urinary retention is a significant cause of urinary tract infections, affecting about 1.7% of hospital patients and increasing the length of hospital stays.

"The SignosRT Bladder weighs less than 400g and fits in the palm of your hand so it’s an easy tool for doctors and nurses to carry anywhere."

The company developed SignosRT Bladder portable devices, in a bid to deploy ultrasound technology to automatically and non-invasively calculate bladder volume, as well as to reduce health care costs in hospitals and home-care support services.

Already available in Australia and New Zealand, the firm’s products can be used in different medical sectors, including urology, aged care, home nursing, midwifery, and palliative care.

This week, the company will exhibit its products at the European Association of Urology (EAU) conference in Madrid, Spain.